SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-002460
Filing Date
2019-02-13
Accepted
2019-02-13 16:07:32
Documents
55
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20181231_10q.htm 10-Q 1062422
2 EXHIBIT 31.1 CERTIFICATION OF CEO ex_134664.htm EX-31.1 12544
3 EXHIBIT 31.2 CERTIFICATION OF CFO ex_134665.htm EX-31.2 12052
4 EXHIBIT 32.1 CERITICATION OF PERIODIC REPORT PURSUANT TO SECTION 302 CEO ex_134662.htm EX-32.1 7331
5 EXHIBIT 32.2 CERTIFICATION OF PERIODIC REPORT PURSUANT TO SECTION 301 CFO ex_134663.htm EX-32.2 6492
  Complete submission text file 0001437749-19-002460.txt   5045383

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20181231.xml EX-101.INS 1178877
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20181231.xsd EX-101.SCH 47361
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20181231_cal.xml EX-101.CAL 37506
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20181231_def.xml EX-101.DEF 305013
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20181231_lab.xml EX-101.LAB 252605
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20181231_pre.xml EX-101.PRE 323110
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 19597135
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1